Elif Engin - Publications

Affiliations: 
Harvard Medical School / McLean Hospital 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Engin E, Benham RS, Rudolph U. An Emerging Circuit Pharmacology of GABA Receptors. Trends in Pharmacological Sciences. PMID 29903580 DOI: 10.1016/j.tips.2018.04.003  0.76
2017 Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U. Corrigendum to "Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors" [Behav. Brain Res. 332 (2017) 172-179]. Behavioural Brain Research. PMID 29070432 DOI: 10.1016/j.bbr.2017.10.006  0.76
2017 Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U. Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors. Behavioural Brain Research. PMID 28587819 DOI: 10.1016/j.bbr.2017.05.063  0.76
2016 Behlke LM, Foster RA, Liu J, Benke D, Benham RS, Nathanson A, Yee BK, Zeilhofer HU, Engin E, Rudolph U. A Pharmaco-Genetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27067130 DOI: 10.1038/npp.2016.49  1
2016 Engin E, Smith KS, Gao Y, Nagy D, Foster RA, Tsvetkov E, Keist R, Crestani F, Fritschy JM, Bolshakov VY, Hajos M, Heldt SA, Rudolph U. Modulation of anxiety and fear via distinct intrahippocampal circuits. Elife. 5. PMID 26971710 DOI: 10.7554/eLife.14120  0.76
2015 Engin E, Zarnowska ED, Benke D, Tsvetkov E, Sigal M, Keist R, Bolshakov VY, Pearce RA, Rudolph U. Tonic Inhibitory Control of Dentate Gyrus Granule Cells by α5-Containing GABAA Receptors Reduces Memory Interference. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 13698-712. PMID 26446222 DOI: 10.1523/JNEUROSCI.1370-15.2015  1
2015 Rodgers FC, Zarnowska ED, Laha KT, Engin E, Zeller A, Keist R, Rudolph U, Pearce RA. Etomidate Impairs Long-Term Potentiation In Vitro by Targeting α5-Subunit Containing GABAA Receptors on Nonpyramidal Cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 9707-16. PMID 26134653 DOI: 10.1523/JNEUROSCI.0315-15.2015  1
2014 Riccio A, Li Y, Tsvetkov E, Gapon S, Yao GL, Smith KS, Engin E, Rudolph U, Bolshakov VY, Clapham DE. Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 3653-67. PMID 24599464 DOI: 10.1523/JNEUROSCI.2274-13.2014  1
2014 Engin E, Bakhurin KI, Smith KS, Hines RM, Reynolds LM, Tang W, Sprengel R, Moss SJ, Rudolph U. Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1805-15. PMID 24553732 DOI: 10.1038/npp.2014.41  1
2014 Benham RS, Engin E, Rudolph U. Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders. Jama Psychiatry. 71: 91-3. PMID 24196284 DOI: 10.1001/jamapsychiatry.2013.3059  1
2012 Engin E, Liu J, Rudolph U. α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacology & Therapeutics. 136: 142-52. PMID 22921455 DOI: 10.1016/j.pharmthera.2012.08.006  1
2012 Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA, Rudolph U. Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2531-40. PMID 22763624 DOI: 10.1038/npp.2012.115  1
2012 Smith KS, Engin E, Meloni EG, Rudolph U. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology. 63: 250-8. PMID 22465203 DOI: 10.1016/j.neuropharm.2012.03.001  1
2011 Yeung M, Engin E, Treit D. Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions. Psychopharmacology. 216: 557-67. PMID 21424237 DOI: 10.1007/s00213-011-2248-x  1
2011 Drexler B, Antkowiak B, Engin E, Rudolph U. Identification and characterization of anesthetic targets by mouse molecular genetics approaches. Canadian Journal of Anaesthesia = Journal Canadien D'AnesthéSie. 58: 178-90. PMID 21174184 DOI: 10.1007/s12630-010-9414-1  1
2010 Treit D, Engin E, McEown K. Animal models of anxiety and anxiolytic drug action. Current Topics in Behavioral Neurosciences. 2: 121-60. PMID 21309109 DOI: 10.1007/7854_2009_17  1
2009 Engin E, Treit D. Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology. 206: 281-9. PMID 19609508 DOI: 10.1007/s00213-009-1605-5  1
2009 Engin E, Treit D, Dickson CT. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience. 161: 359-69. PMID 19321151 DOI: 10.1016/j.neuroscience.2009.03.038  1
2009 Engin E, Treit D, Dickson CT. Corrigendum to "anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models". [Neuroscience 161 (2009) 359-369] (DOI:10.1016/j.neuroscience.2009.03.038) Neuroscience. 162: 1438-1439. DOI: 10.1016/j.neuroscience.2009.06.007  1
2008 Engin E, Stellbrink J, Treit D, Dickson CT. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience. 157: 666-76. PMID 18940236 DOI: 10.1016/j.neuroscience.2008.09.037  1
2008 Engin E, Treit D. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus. Neuropeptides. 42: 411-21. PMID 18508119 DOI: 10.1016/j.npep.2008.04.004  1
2008 Engin E, Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1399-419. PMID 18495312 DOI: 10.1016/j.pnpbp.2008.03.020  1
2007 Engin E, Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behavioural Pharmacology. 18: 461-70. PMID 17762514 DOI: 10.1097/FBP.0b013e3282d28f6f  1
2007 Engin E, Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behavioural Pharmacology. 18: 365-74. PMID 17762507 DOI: 10.1097/FBP.0b013e3282de7929  1
Show low-probability matches.